Skip to main content
. 2017 Nov 2;2(21):e93306. doi: 10.1172/jci.insight.93306

Figure 1. GIP receptor expression in enteroendocrine cells.

Figure 1

Human intestinal sections. (A) Colonal sections double immunostained for glucose-dependent insulinotropic peptide receptor (GIPR) and glucagon-like peptide-1 (GLP-1). (B) Jejunal sections double immunostained for GIPR and glucose-dependent insulinotropic peptide (GIP). Scale bar: 10 μm.